The pharmaceutical world is witnessing a significant shift in blood sugar treatment with the emergence of GLP-1 skin applications. These patches offer a potentially more convenient alternative to subcutaneous administrations of GLP-1 receptor agonists, reducing the need for daily needle pricks. T